to World Health Organization (WHO), first global malaria vaccines will be piloted in the regions
of sub-Saharan Africa in 2018, with the funding to around US$ 15 Mn. The program is partly
funded by the Bill & Melinda Gates Foundation and African Research Centers. Major regions
affected by malaria do not have an appropriate healthcare infrastructure and standard economic
conditions, due to which they are unable to pay for the better treatments and drugs. Malaria is
common in sub-Saharan and African region, due to poor sanitation and healthcare standards.
However, the vaccine is being developed by GSK at their lab in Belgium in collaboration with
Path, which is an international non-profit organization. This ensures the cost effectiveness of
the vaccine though it has taken around 30 years to develop at a cost of US$ 565 Mn. The
company pledges not to make a profit from sales of the vaccine and adheres to the price range
of around US$ 5 per shot.
Market Taxonomy
This report segments the global malaria vaccines market on the basis of vaccines type, by
agent, distribution channel, and geography. On the basis of vaccines type, the malaria vaccines
market is categorized into Pre-Erythrocytic Vaccine, Erythrocytic Vaccine and Multi-antigen
Vaccine. On the basis of agent, the malaria vaccines market is categorized into Plasmodium
Falciparum and Plasmodium Vivax. On the basis of distribution channel, the malaria vaccines
market is categorized into hospital, clinics, and community centers. For comprehensive
understanding of market dynamics, the global malaria vaccines market is analyzed across key
geographical regions namely North America, Europe, Asia Pacific, Latin America, Africa, and
Middle East. Each of these regions is analyzed on basis of market findings across major
countries in these regions for a macro-level understanding of the market.
Request For Customization of Research Report @
https://www.coherentmarketinsights.com/insight/request-customization/37
Key companies covered as a part of this study include GlaxoSmithKline plc, Sanaria Inc.,
Nobelpharma Co., Ltd., Sumaya Biotech and GenVec Inc.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-
ready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.